Safe Orthopaedics SA Total Liabilities
Safe Orthopaedics SA total liabilities. Based on the latest financial reports, Safe Orthopaedics SA (ALSAF) has total liabilities worth €22.49 Million EUR (≈ $26.29 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check ALSAF asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Safe Orthopaedics SA (2012–2025)
Total liabilities of Safe Orthopaedics SA from 2012 to 2025. This chart illustrates how Safe Orthopaedics SA's total liabilities have evolved over time, based on quarterly financial data.
Safe Orthopaedics SA Competitors by Total Liabilities
The table below lists competitors of Safe Orthopaedics SA ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Bay Capital PLC
LSE:BAY
|
UK | GBX91.67K |
|
Angus Energy PLC
LSE:ANGS
|
UK | GBX43.27 Million |
|
Arcontech Group Plc
LSE:ARC
|
UK | GBX2.17 Million |
|
Haydale Graphene Industries
LSE:HAYD
|
UK | GBX6.69 Million |
|
QUICKBIT EU AB O.N.
F:QBT
|
Germany | €13.60 Million |
|
Lexington Gold Ltd
LSE:LEX
|
UK | GBX631.23K |
|
Enlivex Therapeutics Ltd
TA:ENLV
|
Israel | ILA3.46 Million |
|
The Investment Company plc
LSE:INV
|
UK | GBX72.31K |
Liability Composition Analysis (2012–2025)
This chart breaks down Safe Orthopaedics SA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see ALSAF total assets.
Liquidity & Leverage Metrics
Safe Orthopaedics SA Total Liabilities Ratios Explained
Safe Orthopaedics SA total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.41 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -2.11 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.90 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Safe Orthopaedics SA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Safe Orthopaedics SA (2012–2025)
The table below shows the annual total liabilities of Safe Orthopaedics SA from 2012 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €22.49 Million ≈ $26.29 Million |
+15.60% |
| 2024-12-31 | €19.45 Million ≈ $22.74 Million |
-93.06% |
| 2023-12-31 | €280.28 Million ≈ $327.68 Million |
+1474.87% |
| 2022-12-31 | €17.80 Million ≈ $20.81 Million |
+22.89% |
| 2021-12-31 | €14.48 Million ≈ $16.93 Million |
+2.64% |
| 2020-12-31 | €14.11 Million ≈ $16.50 Million |
+42.19% |
| 2019-12-31 | €9.92 Million ≈ $11.60 Million |
+34.46% |
| 2018-12-31 | €7.38 Million ≈ $8.63 Million |
+5.43% |
| 2017-12-31 | €7.00 Million ≈ $8.18 Million |
-8.34% |
| 2016-12-31 | €7.64 Million ≈ $8.93 Million |
+42.35% |
| 2015-12-31 | €5.37 Million ≈ $6.27 Million |
+87.59% |
| 2014-12-31 | €2.86 Million ≈ $3.34 Million |
-33.69% |
| 2013-12-31 | €4.31 Million ≈ $5.04 Million |
+84.63% |
| 2012-12-31 | €2.34 Million ≈ $2.73 Million |
-- |
About Safe Orthopaedics SA
Safe Orthopaedics SA, a medical technology company, develops and markets ready-to-use implants and sterile instrumentation for spinal surgery in France. It offers SteriSpine PS, an all-round kit for open, mini open, and MIS surgeries, as well as percutaneous kit; SteriSpine VA, a product platform for ready to use Kyphoplasty and Cement systems; SteriSpine LC, a ready to use instrumentation for lu… Read more